REG - MicroSalt PLC - Signed Joint Development Agreement

MicroSaltAnnouncement

27/01/2026 07:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260127:nRSa5171Qa&default-theme=true

RNS Number : 5171Q  MicroSalt PLC  27 January 2026

27 January 2026

MicroSalt Plc

 

("MicroSalt" or the "Company")

 

Signed Joint Development Agreement

 

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt
with approximately 50% less sodium, is pleased to announce that it has entered
into a formal Joint Development Agreement ("JDA") with Customer 3, one of the
world's largest food, soft drink and snack manufacturers (the "Partner").

 

This agreement follows the Company's announcement on 14 November 2025
regarding the signing of a non-binding term sheet between the parties.

 

The JDA provides a framework for a four-year collaboration between MicroSalt
and the Partner focused on the joint development of new food solutions that
significantly reduce sodium content, while maintaining a salty and savoury
taste experiences for consumers. The agreement reflects the continued
expansion in both the depth and breadth of the relationship between the two
parties and will continue to build on existing commercial engagements.

 

Unless otherwise expressly agreed within the scope of individual projects, no
compensation will be exchanged between the parties, and each party will bear
its own costs incurred in connection with the collaboration.

 

The signing of the JDA represents an important milestone for MicroSalt,
providing increased visibility over future development activity and
reinforcing the Company's position as a strategic partner to global food
manufacturers seeking practical, scalable sodium-reduction solutions.

 

Rick Guiney, Chief Executive Officer of MicroSalt, commented:

"This further agreement with Customer 3 is a validation of MicroSalt's unique
offering to the global food and beverage industry. Collaborating with one of
the world's largest food, soft drink and snack manufacturers underlines the
strength and versatility of our technology that addresses one of the food
industry's most pressing challenges. We look forward to working evermore
closely with Customer 3 to deliver healthier food products to consumers
worldwide in the coming years."

 

 

Enquiries:

 

 MicroSalt plc                                    info@microsaltinc.com
 Rick Guiney (CEO)

 Zeus (Nominated Adviser and Broker)              +44 (0)20 3829 5000
 David Foreman / James Edis (Investment Banking)
 Dom King (Broking) / Rupert Woolfenden (Sales)

 Gracechurch Group (Financial PR)                 +44 (0)20 4582 3500
 Heather Armstrong, Alexis Gore, Rebecca Scott

 

 

About MicroSalt

 

MicroSalt® is disrupting the global salt market with its patented,
full-flavour, low-sodium salt designed for both food manufacturers and
consumers. Using proprietary micron-sized particles, MicroSalt® delivers the
same salty taste as traditional salt with approximately 50% less sodium,
offering a scalable solution to one of the world's most pressing health
challenges. Year to date through 2025, MicroSalt® has contributed to more
than 634M servings made healthier.

 

Excess sodium consumption is a leading contributor to cardiovascular disease,
the world's number one cause of death. The World Health Organisation has
targeted a 30% reduction in global sodium intake by 2025, a shift projected to
save seven million lives by 2030. The economic case is equally compelling: in
the UK alone, cardiovascular disease costs £19 billion annually, and reducing
average daily salt intake by just one gram could save over 4,000 lives and
£288 million each year.

 

Operational since 2018, MicroSalt® has established a defensible IP portfolio,
holding a granted US patent and 14 pending applications worldwide. These
protections create significant barriers to entry in a market expected to grow
exponentially as regulation and consumer demand accelerate.

 

MicroSalt® is ideally positioned for scale and market leadership, with clear
pathways into food manufacturing, consumer channels, and ultimately the
broader £10+ billion global salt market. MicroSalt® is more than a healthier
alternative-it is a disruptive, category-defining solution poised to deliver
significant commercial and societal impact.

 

For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) or follow on X @microSaltPLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  JVEMZGZMNNLGVZG



            Copyright 2019 Regulatory News Service, all rights reserved